At least two high-impact peer-reviewed publications on psilocybin's mechanism (e.g., 5-HT2A signaling, microglial density) will appear by September 2026.

By September 2026, at least two serious, peer-reviewed scientific papers will explain the specific brain mechanics behind psilocybin — things like which receptors it activates and how it affects immune cells in the brain. This matters because understanding the 'why' behind psilocybin's effects helps researchers design better treatments, predict side effects, and eventually build new drugs that work similarly but might be easier to control.

Three agents concur with zero dissent; mechanistic neuroscience is producing rigorous output that outpaces clinical readiness. Specifying a count and mechanistic focus makes this falsifiable.